Back to today’s briefing

Story perspectives

New Molecule TDN Offers Hope for Obesity and Diabetes

8/7/2025

44 6

Summary

Story summary

Syracuse University professor Robert Doyle is at the forefront of a groundbreaking study on obesity and diabetes. His team discovered tridecaneuropeptide (TDN), a molecule from brain support cells that curbs appetite without adverse effects. In trials, TDN not only aided weight loss in obese animals but also enhanced insulin response, presenting a hopeful alternative to existing GLP-1 medications.

1 of 1

Story summary

Syracuse University professor Robert Doyle is at the forefront of a groundbreaking study on obesity and diabetes. His team discovered tridecaneuropeptide (TDN), a molecule from brain support cells that curbs appetite without adverse effects. In trials, TDN not only aided weight loss in obese animals but also enhanced insulin response, presenting a hopeful alternative to existing GLP-1 medications.